Osteonic Co. Ltd. (226400) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Osteonic Co. Ltd. (226400:KRX), powered by AI.

Current Price
₩4,575
P/E Ratio
12.6
Market Cap
94.5B
Sector
Healthcare
What is the Osteonic Co. Ltd. stock price forecast?

Osteonic Co. Ltd. is currently trading at ₩4,575. View real-time AI analysis on Alpha Lenz.

What is Osteonic Co. Ltd. insider trading activity?

View the latest insider trading data for Osteonic Co. Ltd. on Alpha Lenz.

What is Osteonic Co. Ltd.'s P/E ratio?

Osteonic Co. Ltd.'s P/E ratio is 12.6.

Osteonic Co. Ltd.

KRX · 226400
₩4,575+25(+0.55%)Market closedKRX regular session 09:00–15:30 KST
Ask about Osteonic Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Osteonic Co. Ltd. trades at a P/E of 12.6 (undervalued) with solid ROE of 11.8%. 3Y revenue CAGR of 31.8% highlights clear growth momentum.

Ask for details

Company Overview

Osteonic Co. Ltd. is a leading company in the medical device industry, specializing in the design, manufacture, and distribution of orthopedic surgical implants and instruments. Its primary function is to provide high-quality, innovative solutions for orthopedic surgeries, which are crucial for treating musculoskeletal conditions and injuries. Serving both local and international markets, Osteonic Co. Ltd. plays a vital role in the healthcare sector by enabling surgeons to perform efficient and effective surgical procedures, thereby improving patient outcomes. The company's diverse product portfolio includes a range of implants such as bone plates, screws, and joint replacement systems, catering to various specialties within orthopedics like spine, trauma, and reconstructive surgeries. By focusing on research and development, Osteonic Co. Ltd. continuously advances its technology to meet the evolving needs of the medical community and enhance patient care. In the financial market, the company holds significant importance as a distinguished provider within the medical sector, contributing to advancements in healthcare through its commitment to innovation and quality assurance."}iventified in the following: 2290 in the body. 2290 in the synonym.

CEO이동원
SectorHealthcare
IndustryMedical Devices
Employees185

Company Statistics

FY 2025

Profile

₩94,526,824,575Market Cap
₩45,393,099,430Revenue
20.66MShares Out
185Employees

Margins

48.61%Gross
34.49%EBITDA
19.53%Operating
18.56%Pre-Tax
16.52%Net

Valuation

12.61P/E
1.40P/B
2.08EV/Sales
6.51EV/EBITDA
1452.25P/FCF

Growth (CAGR)

31.77%Rev 3Yr
29.19%Rev 5Yr
51.96%Op Inc 3Yr
107.93%Op Inc 5Yr
107.81%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

7.88%ROA
11.83%ROE
10.08%ROIC

Financial Health

₩14,443,897,270Cash & Cash Equivalents
₩18,407,224,370Net Debt
48.61%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Osteonic Co. Ltd. (ticker: 226400) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 185 employees. Market cap is $94.5B.

The current price is ₩4,575 with a P/E ratio of 12.61x and P/B of 1.4x.

ROE is 11.83% and operating margin is 19.53%. Annual revenue is $45.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Osteonic Co. Ltd. (226400) Stock Forecast 2026 ₩4,575 — Price, Financials & Analyst Targets | Alpha Lenz